About Authors:
Kapil Sharma*, Priyanka sharma**
*Yaresun Pharmaceutical Pvt Ltd,India
**M.sc. Student, Rajasthan, India
*pharma_kapil@rediffmail.com
1. INTRODUCTION
The mammalian intestinal tract contains a complex and diverse society of both pathogenic and non pathogenic bacteria. Most research to date has focused on the mechanism by which pathogenic bacteria achieve their detrimental effect. However, more recent research has unveiled a glimpse into the mechanism of action and potential therapeutic role of indigenious non pathtogenic microorganisms (probiotic).
Probiotic, prebiotic, and synbiotic are moving from snake oil into the mainstream of medical therapy. This evolution has been facilitated by our ever increasing understanding of the mechanism of action of these agents and by the development of molecular method for analyzing and identifying complex bacterial community within the mammalian intestine.1, 2
(adsbygoogle = window.adsbygoogle || []).push({});